Dunér, Pontus
Mattisson, Ingrid Yao
Fogelstrand, Per
Glise, Lars
Ruiz, Stacey
Farina, Christopher
Borén, Jan
Nilsson, Jan
Bengtsson, Eva
Article History
Received: 19 November 2020
Accepted: 9 April 2021
First Online: 27 April 2021
Competing interests
: Jan Nilsson is signed as co-inventor on patents of the use of apoB peptides in immune-modulatory treatment for prevention assigned to Abcentra. He is also an Abcentra board member. Stacey Ruiz is an employee of Abcentra and co-inventor on patents of the use antibodies against apoB100 to treat human diseases. Christopher Farina is an employee of Abcentra and co-inventor on patents of the use antibodies against apoB100 to treat human diseases. Pontus Dunér, Ingrid Yao Mattisson, Per Fogelstrand, Lars Glise, Jan Borén and Eva Bengtsson declare no competing interests.